All posts by: Michael Zand

About Michael Zand

First efficacy trial of Athersys stem cell therapy yields disappointing … – MedCity News

MedCity NewsShare This Story. IV drip hospital patient Edited to include comments from CEO. Halfway through its first large-scale efficacy trial, Athersys’s experimental stem cell therapy did not provide significant benefit to patients with moderate-to-severe …Athersys Inc. stem cell therapy for bowel disease fails to show ‘meaningful …Crain’s Cleveland BusinessAthersys stem–cell therapy for bowel disease … Continue reading

2014-04-28 NEWS

Japan’s Latest Stem Cell Apology – Science News

Science NewsNobel Prize winner Shinya Yamanaka today joined a growing crowd of Japanese stem cell scientists who have held press conferences in recent weeks to apologize for mistakes in published papers. Yamanaka discovered in 2006 a way to reprogram adult …Japanese Nobel Winner Latest to Apologize Over Stem–Cell ResearchWall Street Journal (blog)Japanese Nobel laureate also … Continue reading

2014-04-28 NEWS